|
treatments
|
Treatments |
nma.acr.naive nma.das28.naive nma.haq.naive
|
NMA estimates |
acr2das28
|
Change in DAS28 by 6-month ACR response |
acr2sdai
|
Change in SDAI by 6-month ACR response |
acr2cdai
|
Change in CDAI by 6-month ACR response |
acr2haq
|
HAQ change by 6-month ACR response |
acr2eular
|
ACR to EULAR Conversion |
eular2haq
|
HAQ change by 6-month EULAR Response |
haq.lprog
|
Linear HAQ progression rates |
haq.lcgm
|
Latent Class Growth Model (LCGM) for HAQ progression |
ttd.eular ttd.da ttd.all
|
Time to treatment discontinuation parameters |
ttsi
|
Time to serious infection parameters |
lifetable.female lifetable.male
|
US Lifetables 2011 |
mort.or
|
Mortality odds ratios by patient characteristics |
mort.hr.haqdif
|
Mortality hazard ratio for change in HAQ score |
tx.cost
|
Treatment costs |
hosp.cost
|
Hospitalization costs |
mgmt.cost
|
Cost of general management of RA |
pain
|
Correlation between HAQ and pain |
utility.mixture
|
Mixture model utility mapping |
utility.wailoo
|
Wailoo (2006) utility mapping |
utility.tx.attr
|
Treatment attributes |